Papillary renal cell carcinoma: a single institutional study of 199 cases addressing classification, clinicopathologic and molecular features, and treatment outcome.

MLA

Murugan, Paari, et al. “Papillary Renal Cell Carcinoma: A Single Institutional Study of 199 Cases Addressing Classification, Clinicopathologic and Molecular Features, and Treatment Outcome.” Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc, vol. 35, no. 6, June 2022, pp. 825–35. EBSCOhost, https://doi.org/10.1038/s41379-021-00990-9.

APA

Murugan, P., Jia, L., Dinatale, R. G., Assel, M., Benfante, N., Al-Ahmadie, H. A., Fine, S. W., Gopalan, A., Sarungbam, J., Sirintrapun, S. J., Hakimi, A. A., Russo, P., Chen, Y.-B., Tickoo, S. K., & Reuter, V. E. (2022). Papillary renal cell carcinoma: a single institutional study of 199 cases addressing classification, clinicopathologic and molecular features, and treatment outcome. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc, 35(6), 825–835. https://doi.org/10.1038/s41379-021-00990-9

Chicago

Murugan, Paari, Liwei Jia, Renzo G Dinatale, Melissa Assel, Nicole Benfante, Hikmat A Al-Ahmadie, Samson W Fine, et al. 2022. “Papillary Renal Cell Carcinoma: A Single Institutional Study of 199 Cases Addressing Classification, Clinicopathologic and Molecular Features, and Treatment Outcome.” Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc 35 (6): 825–35. doi:10.1038/s41379-021-00990-9.